A. Takama

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhiko Tsukada, J. Saito, T. Ishii, 2021, medRxiv.